This center for Research on Substance Abuse includes a Core and eight major projects organized into three Divisions for medication development: 1. preclinical neurobiology, 2. human laboratory studies and 3. clinical trials. The Core has stimulated novel approaches to cocaine neurobiology and pharmacotherapy by coordinating research efforts across Psychiatry, Pharmacology, Nuclear Medicine and Laboratory Medicine. It has developed innovative research ideas into current Center proposals (e.g. buproprion pilot, cocaine cue reactivity, place preference in animals), as well as into projects that were later independently funded (e.g. HIV dementia, flupenthixol pilot, desipramine in methadone pilot). Core resources have also provided technical and material assistance in trainee' research projects that have led to independently funded research (e.g. mazindol pilot, amantadine pilot). Proposed pilot studies in the Core (e.g. disulfiram for alcoholic cocaine abusers, anxiety disorders and cocaine) should continue this tradition. Three of the eight major projects are continuations of our previous work: 1. the neurobiology of cocaine withdraw, 2. cocaine challenges during maintenance pharmacotherapies, 3. metabolic studies of cocaine focusing on the interaction of cocaine with alcohol. The other original Center projects have led to independently funded grants such as the three current buprenorphine studies, and no longer need Center funding. Five new projects evolved from Core pilot work: 1. animal models to screen medications and to understand the molecular mechanisms of cocaine's actions, 2. SPECT imaging of stimulant effects on dopamine neurobiology in primates and humans, 3. human laboratory studies of cocaine cue reactivity during neurotransmitter manipulation and during maintenance pharmacotherapy, and 4,5. clinical trials with buproprion and carbamazapine. Two new clinical sites have been added to increase the investigator and subject pools for studies: West Haven V.A. and the University of Connecticut. Thus, both continuity with our current Center and major new initiates towards a broad based medication development program have been incorporated into the continuation of our Research Center.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
2P50DA004060-06
Application #
3105357
Study Section
Special Emphasis Panel (SRCD (46))
Project Start
1986-08-01
Project End
1996-08-31
Budget Start
1991-09-13
Budget End
1992-08-31
Support Year
6
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Bradberry, Charles W (2011) Cortical and sub-cortical effects in primate models of cocaine use: implications for addiction and the increased risk of psychiatric illness. Neurotox Res 19:235-42
Greenwell, Thomas N; Martin-Schild, Sheryl; Inglis, Fiona M et al. (2007) Colocalization and shared distribution of endomorphins with substance P, calcitonin gene-related peptide, gamma-aminobutyric acid, and the mu opioid receptor. J Comp Neurol 503:319-33
Kosten, Thomas R; Scanley, Barbara Ellen; Tucker, Karen A et al. (2006) Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology 31:644-50
Abi-Saab, Danielle; Beauvais, John; Mehm, John et al. (2005) The effect of alcohol on the neuropsychological functioning of recently abstinent cocaine-dependent subjects. Am J Addict 14:166-78
Kosten, Thomas R; Tucker, Karen; Gottschalk, P Christopher et al. (2004) Platelet abnormalities associated with cerebral perfusion defects in cocaine dependence. Biol Psychiatry 55:91-7
Tucker, Karen A; Browndyke, Jeffrey N; Gottschalk, P Christopher et al. (2004) Gender-specific vulnerability for rCBF abnormalities among cocaine abusers. Neuroreport 15:797-801
Kosten, Thomas R; Kosten, Therese A (2004) New medication strategies for comorbid substance use and bipolar affective disorders. Biol Psychiatry 56:771-7
Tucker, Karen A; Potenza, Marc N; Beauvais, John E et al. (2004) Perfusion abnormalities and decision making in cocaine dependence. Biol Psychiatry 56:527-30
Browndyke, Jeffrey N; Tucker, Karen A; Woods, Steven P et al. (2004) Examining the effect of cerebral perfusion abnormality magnitude on cognitive performance in recently abstinent chronic cocaine abusers. J Neuroimaging 14:162-9
Kosten, Thomas R; Gottschalk, P Christopher; Tucker, Karen et al. (2003) Aspirin or amiloride for cerebral perfusion defects in cocaine dependence. Drug Alcohol Depend 71:187-94

Showing the most recent 10 out of 188 publications